| Literature DB >> 29502286 |
Wenhua Pei1, Tengfei Lu1, Kunfu Wang2, Meng Ji1, Shuang Zhang3, Fenghao Chen4, Lu Li5, Xiangchen Li6, Weijun Guan7.
Abstract
Mesenchymal stem cells derived from amniotic fluid have become one of the most potential stem cell source for cell-based therapy for the reason they can be harvested at low cost and without ethical problems. Here, we obtained amniotic fluid stem cells (AFSCs) from ovine amniotic fluid and studied the expansion capacity, cell markers expression, karyotype, and multilineage differentiation ability. In our work, AFSCs were subcultured to passage 62. The cell markers, CD29, CD44, CD73 and OCT4 which analyzed by RT-PCR were positive; CD44, CD73, CD90, CD105, NANOG, OCT4 analyzed by immunofluorescence and flow cytometry were also positive. The growth curves of different passages were all typically sigmoidal. The different passages cells took on a normal karyotype. In addition, AFSCs were successfully induced to differentiate into adipocytes, osteoblasts and chondrocytes. The results suggested that the AFSCs isolated from ovine maintained normal biological characteristics and their multilineage differentiation potential provides many potential applications in cell-based therapies and tissue engineering.Entities:
Keywords: Amniotic fluid; Differentiation; Ovine; Stem cell
Year: 2018 PMID: 29502286 PMCID: PMC6021295 DOI: 10.1007/s10616-017-0115-2
Source DB: PubMed Journal: Cytotechnology ISSN: 0920-9069 Impact factor: 2.058